Resources

 

 

2025

• Micheau O., Fournel S. Comment on “Self-Illuminating NanoagonistSimultaneously Induces Dual Cell DeathPathways via Death Receptor Clustering forCancer Therapy”. AcsNANO. 2025 Jan 19(1):1. doi: 10.1021.acsnano.4c17726.

​

2024

• ​Guerrache A, Micheau O. TNF-Related Apoptosis-Inducing Ligand: Non-ApoptoticSignalling. Cells. 2024 Mar 16;13(6):521. doi: 10.3390/cells13060521. PMID:38534365; PMCID: PMC10968836.

 

2023

• Gunalp S, Helvaci DG, Oner A, Bursalı A, Conforte A, Güner H, Karakülah G, Szegezdi E, Sag D. TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content. Front Immunol. 2023 Sep 21;14:1209249. doi: 10.3389/fimmu.2023.1209249. PMID: 37809073; PMCID: PMC10551148.

• Alizadeh Zeinabad H, Yeoh WJ, Arif M, Lomora M, Banz Y, Riether C, Krebs P, Szegezdi E. Natural killer cell-mimic nanoparticles can actively target and kill acute myeloid leukemia cells. Biomaterials. 2023 Jul;298:122126. doi: 10.1016/j.biomaterials.2023.122126. PMID: 37094524.

• Groeneveld CS, Sanchez-Quiles V, Dufour F, Shi M, Dingli F, Nicolle R, Chapeaublanc E, Poullet P, Jeffery D, Krucker C, Maillé P, Vacherot F, Vordos D, Benhamou S, Lebret T, Micheau O, Zinovyev A, Loew D, Allory Y, de Reyniès A, Bernard-Pierrot I, Radvanyi F. Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors. Eur Urol. 2023 Jun 27:S0302-2838(23)02885-3. doi: 10.1016/j.eururo.2023.05.037. Epub ahead of print. PMID: 37380559.

• Ennis S, Conforte A, O'Reilly E, Takanlu JS, Cichocka T, Dhami SP, Nicholson P, Krebs P, Ó Broin P, Szegezdi E. Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia. iScience. 2023 May 23;26(6):106943. doi: 10.1016/j.isci.2023.106943. PMID: 37332612; PMCID: PMC10275994.

• Radoua A, Pernon B, Pernet N, Jean C, Elmallah M, Guerrache A, Constantinescu AA, Hadj Hamou S, Devy J, Micheau O. ptARgenOM-A Flexible Vector For CRISPR/CAS9 Nonviral Delivery. Small Methods. 2023 Jul;7(7):e2300069. doi: 10.1002/smtd.202300069. Epub 2023 May 8. PMID: 37156748.

​

2022

• Gurney M, O'Reilly E, Corcoran S, Brophy S, Krawczyk J, Otto NM, Hermanson DL, Childs RW, Szegezdi E, O'Dwyer ME. Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cells. Cytotherapy. 2022 Nov;24(11):1087-1094. doi: 10.1016/j.jcyt.2022.07.008. Epub 2022 Aug 29. PMID: 36050244.

• Alizadeh Zeinabad H, Szegezdi E. TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems. Cancers (Basel). 2022 Oct 19;14(20):5125. doi: 10.3390/cancers14205125. PMID: 36291908; PMCID: PMC9600485.

• Zischler L, Cogo SC, Micheau O, Elifio-Esposito S. Evidence that BJcuL, a C-type lectin from Bothrops jararacussu venom, influences deubiquitinase activity, resulting in the accumulation of anti-apoptotic proteins in two colorectal cancer cell lines. Int J Biol Macromol. 2022 Jun 1;209(PtA):1205-1210. doi: 10.1016/j.ijbiomac.2022.04.092. Epub 2022 Apr 21. PMID: 35461862.

• Unuvar Purcu D, Korkmaz A, Gunalp S, Helvaci DG, Erdal Y, Dogan Y, Suner A, Wingender G, Sag D. Effect of stimulation time on the expression of human macrophage polarization markers. PLoS One. 2022 Mar 14;17(3):e0265196. doi: 10.1371/journal.pone.0265196. PMID: 35286356; PMCID: PMC8920204.

• Gurney M, Stikvoort A, Nolan E, Kirkham-McCarthy L, Khoruzhenko S, Shivakumar R, Zweegman S, Van de Donk NWCJ, Mutis T, Szegezdi E, Sarkar S, O'Dwyer M. CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide. Haematologica. 2022 Feb 1;107(2):437-445. doi: 10.3324/haematol.2020.271908. PMID: 33375774; PMCID: PMC8804573.

 

2021

• Airiau K, Vacher P, Micheau O, Prouzet-Mauleon V, Kroemer G, Moosavi MA, Djavaheri-Mergny M. TRAIL Triggers CRAC-Dependent Calcium Influx and Apoptosis through the Recruitment of Autophagy Proteins to Death-Inducing Signaling Complex. Cells. 2021 Dec 25;11(1):57. doi: 10.3390/cells11010057. PMID: 35011619; PMCID: PMC8750441.

• Micheau O, Rizzi M, Smulski CR. Editorial: TNFR Superfamily Oligomerization and Signaling. Front Cell Dev Biol. 2021 Apr 20;9:682472. doi: 10.3389/fcell.2021.682472. PMID: 33959618; PMCID: PMC8093801.

• Cardoso Alves L, Corazza N, Micheau O, Krebs P. The multifaceted role of TRAIL signaling in cancer and immunity. FEBS J. 2021 Oct;288(19):5530-5554. doi: 10.1111/febs.15637. Epub 2020 Dec 9. PMID: 33215853.

​

2020

• Elmallah MIY, Cogo S, Constantinescu AA, Elifio-Esposito S, Abdelfattah MS, Micheau O. Marine Actinomycetes-Derived Secondary Metabolites Overcome TRAIL-Resistance via the Intrinsic Pathway through Downregulation of Survivin and XIAP. Cells. 2020 Jul 22;9(8):1760. doi: 10.3390/cells9081760. PMID: 32708048; PMCID: PMC7464567.

• Cardoso Alves L, Berger MD, Koutsandreas T, Kirschke N, Lauer C, Spörri R, Chatziioannou A, Corazza N, Krebs P. Non-apoptotic TRAIL function modulates NK cell activity during viral infection. EMBO Rep. 2020 Jan 7;21(1):e48789. doi: 10.15252/embr.201948789. PMID: 31742873; PMCID: PMC6945065.

 

2019

• Cardoso Alves L, Berger MD, Koutsandreas T, Kirschke N, Lauer C, Spörri R, Chatziioannou A, Corazza N, Krebs P. Non-apoptotic TRAIL function modulates NK cell activity during viral infection. EMBO Rep. 2020 Jan 7;21(1):e48789. doi: 10.15252/embr.201948789. Epub 2019 Nov 19. PMID: 31742873; PMCID: PMC6945065.

• Sag D, Ayyildiz ZO, Gunalp S, Wingender G. The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses. Cancers (Basel). 2019 Sep 30;11(10):1469. doi: 10.3390/cancers11101469. PMID: 31574961; PMCID: PMC6826877.

• Belkahla H, Mazarío E, Sangnier AP, Lomas JS, Gharbi T, Ammar S, Micheau O, Wilhelm C, Hémadi M. TRAIL acts synergistically with iron oxide nanocluster-mediated magneto- and photothermia. Theranostics. 2019 Aug 14;9(20):5924-5936. doi: 10.7150/thno.36320. PMID: 31534529; PMCID: PMC6735372.

• Dubuisson A, Favreau C, Fourmaux E, Lareure S, Rodrigues-Saraiva R, Pellat-Deceunynck C, El Alaoui S, Micheau O. Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization. Cell Death Dis. 2019 Feb 4;10(2):101. doi: 10.1038/s41419-019-1343-5. PMID: 30718507; PMCID: PMC6362131.

​

2018

• Micheau O. Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation. Int J Mol Sci. 2018 Mar 2;19(3):715. doi: 10.3390/ijms19030715. PMID: 29498673; PMCID: PMC5877576.